Elevated Plasma Proglucagon-like Component with a Glucagon-Secreting Tumor: Effect of Streptozotocin

New England Journal of Medicine

Volumn 295, Issue 5, 1976, Pages 242-245

  Danforth, David N ^a   Triche, Timothy ^a   Doppman, John L ^a   Beazley, Robert M ^a   Perrino, Pasqual V ^a   Recant, Lillian ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCAGON ANTIBODY; GLUCAGON I 125; INSULIN; INSULIN I 125; PROGLUCAGON; STREPTOZOCIN; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ARTICLE; ECTOPIC HORMONE PRODUCTION; GEL FILTRATION; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET CELL CARCINOMA; THERAPY; TUMOR;

EID: 0017164030     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197607292950502     Document Type: Article

References (19)

1. McGavran MH, Unger RH, Recant L, et al: A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 274: 1408–1413, 1966
2. Mallinson CN, Bloom SR, Warin AP, et al: A glucagonoma syndrome. Lancet 2: 1–5, 1974
3. Case Records of the Massachusetts General Hospital. (Case 20–1975). N Engl J Med 292: 1117–1123, 1975
4. Valverde I, Villanueva ML, Lozano I, et al: Presence of glucagon immunoreactivity in the globulin fraction of human plasma (“Big Plasma Glucagon”). J Clin Endocrinol Metab 39: 1090–1098, 1974
5. Murray-Lyon IM, Eddleston ALWF, Williams R: Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet 2: 895–898, 1968
6. Sternberger LA, Harcy PH Jr, Cuculis JJ: The unlabelled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen–antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in the identification of spirochetes. J Histochem Cytochem 18: 315–333, 1970
7. Graham RC, Karnovsky MJ: The early stages of absorption of injected horseradish peroxidase in the proximal tubules of the mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem 14: 291–302, 1966
8. Unger RH, Eisentraut AM, McCall MS, et al: Glucagon antibodies and their use for immunoassay for glucagon. Proc Soc Exp Biol Med 102: 621–623, 1959
9. Morgan CR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12: 115–126, 1963
10. Davoren PR: The isolation of insulin from a single cat pancreas. Biochim Biophys Acta 63: 150–153, 1962
11. Said SI, Faloona GR: Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. N Engl J Med 293: 155–160, 1975
12. Sasaki H, Rubalcava B, Baetens D, et al: Identification of glucagon in the gastrointestinal tract. J Clin Invest 56: 135–145, 1975
13. Zahlten RN, Stratman FW: The isolation of hormone-sensitive rat hepatocytes by a modified enzymatic technique. Arch Biochem Biophys 163: 600–608, 1974
14. Gilman AG: A protein binding assay for adenosine 3′5′-cyclic monophosphate. Proc Natl Acad Sci USA 67: 305–312, 1970
15. Valverde I, Dobbs R, Unger RH: Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized and alloxan-diabetic dogs. Metabolism 24: 1021–1028, 1975
16. Leichter SB, Pagliara AS, Greider MH, et al: Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma. Am J Med 58: 285–293, 1973
17. O'Connor KJ, Gay A, Lazarus NR: The biosynthesis of glucagon in perfused rat pancreas. Biochem J 134: 473–480, 1973
18. Noe BD, Bauer GE: Evidence for glucagon biosynthesis involving a protein intermediate in islets of anglerfish (Lophius americanus). Endocrinology 89: 642–651, 1971
19. Unger RH, Aguilar-Parada E, Müller WA, et al: Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49: 837–848, 1970